A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
Status:
Completed
Trial end date:
2018-08-31
Target enrollment:
Participant gender:
Summary
This trial will be a double-blind, randomized, placebo-controlled, safety, tolerability and
efficacy trial of SAN007 (5% East Indian sandalwood oil in a cream formulation) treatment
regimen when administered daily for up to 28 days to patients at least 18 years of age, with
atopic dermatitis.
Phase:
Phase 2
Details
Lead Sponsor:
Santalis Pharmaceuticals, Inc.
Collaborators:
ClinDatrix, Inc. Clinical Trials of Texas, Inc. Derm Research, PLLC Progressive Clinical Research Texas Dermatology and Laser Specialists U.S. Dermatology Partners Bryan